An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, ...

About 5 to 10% of breast cancer cases are linked to inherited gene mutations, which is why doctors recommend all women complete a risk assessment by age 25 to determine if they should get further ...

The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...

Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and ...

Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different genetic paths. A new study shows that these differences can sometimes be traced ...

Moderate levels of mitochondrial DNA mutations may promote cancer more effectively than either low or high levels. And metabolic plasticity appears to be a key driver. After decades of fixating on ...

Genmab (GMAB) and Incyte (INCY) announced a clinical trial collaboration to evaluate a combination of their experimental ...

An expert at ESMO 2026 explains how liquid biopsy and ESR1 testing can help guide treatment for people with HR-positive metastatic breast cancer. A simple blood test can help oncologists track how ...

A single sperm donor who carries a rare cancer-causing genetic mutation has fathered at least 197 children across 14 countries in Europe, according to a collaborative investigation by 14 European news ...

At one of the year’s premiere meetings for cancer research, melanoma vaccine data hailed by scientists sparked a share ...

If you have estrogen receptor-positive (ER-positive) metastatic breast cancer, your doctor will most likely recommend hormone (endocrine) therapy. That's because the estrogen hormone can attach to ...

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...